Related Experiment Video
Updated: Jul 5, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Psoriasis and dilated cardiomyopathy: coincidence or associated diseases?
Noa Eliakim-Raz1, Mony Shuvy, Chaim Lotan
1Department of Cardiology, Hebrew University-Hadassah Medical School, Jerusalem, Israel. noaeliakim@gmail.com
Insights
Psoriasis patients show a higher prevalence of dilated cardiomyopathy. This suggests shared genetic or immune factors may link these conditions, impacting heart health.
Area of Science:
- Cardiology
- Immunology
- Dermatology
Background:
- Psoriasis is a prevalent immune-mediated skin condition.
- Dilated cardiomyopathy is a serious heart condition with various potential causes.
- The link between psoriasis and dilated cardiomyopathy is not well understood.
Observation:
- A computerized search revealed an increased prevalence of cardiomyopathy, particularly dilated cardiomyopathy, in patients hospitalized with psoriasis.
- Four patients with both psoriasis and dilated cardiomyopathy were identified.
Findings:
- The study suggests an association between pre-existing psoriasis and dilated cardiomyopathy.
- Potential shared genetic risk factors between psoriasis (especially psoriatic arthritis) and dilated cardiomyopathy are proposed.
- Immune reactions and chronic inflammation in psoriasis may contribute to dilated cardiomyopathy progression.
Implications:
- Further research into shared genetic and immune pathways could illuminate the pathogenesis of dilated cardiomyopathy.
- Understanding these links may lead to improved treatment strategies for dilated cardiomyopathy in psoriatic patients.
Abstract:
Psoriasis is a common immune-mediated disease which affects 1-3% of the population. The etiology of psoriasis is unknown. Idiopathic dilated cardiomyopathy is probably the end result of a variety of toxic, metabolic or infectious agents. During a computerized search for cardiomyopathy among all patients hospitalized with psoriasis in the Hadassah University Hospital since 1980 we found an increased prevalence of cardiomyopathy, and specifically dilated cardiomyopathy. We present 4 patients who suffer from both conditions. In accordance with previous data, an association between preexisting psoriasis and dilated cardiomyopathy is suggested. We suggest that the genetic risk factors of dilated cardiomyopathy are shared by psoriasis, and more specifically psoriatic arthritis. Alternatively, the immune reaction that is triggered in dilated cardiomyopathy leading to the progression of the disease might be enhanced in patients with psoriasis or psoriatic arthritis. Chronic inflammation and persistent secretion of proinflammatory cytokines may be considered a potential pathway, triggering the initiation and progression of dilated cardiomyopathy in psoriatic patients. Further investigation of the genetic and immune risk factors involved in dilated cardiomyopathy and in psoriasis may lead to a better understanding of the pathogenesis and treatment of dilated cardiomyopathy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy